These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9033399)

  • 21. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.
    Arion D; Kaushik N; McCormick S; Borkow G; Parniak MA
    Biochemistry; 1998 Nov; 37(45):15908-17. PubMed ID: 9843396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.
    Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2001 May; 75(10):4832-42. PubMed ID: 11312355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
    Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
    J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues.
    Deval J; Selmi B; Boretto J; Egloff MP; Guerreiro C; Sarfati S; Canard B
    J Biol Chem; 2002 Nov; 277(44):42097-104. PubMed ID: 12194983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative kinetic analyses of interaction of inhibitors with Rauscher murine leukemia virus and human immunodeficiency virus reverse transcriptases.
    Cherrington JM; Fuller MD; Mulato AS; Allen SJ; Kunder SC; Ussery MA; Lesnikowski Z; Schinazi RF; Sommadossi JP; Chen MS
    Antimicrob Agents Chemother; 1996 May; 40(5):1270-3. PubMed ID: 8723481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase.
    Feng JY; Anderson KS
    Biochemistry; 1999 Jul; 38(29):9440-8. PubMed ID: 10413520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.
    Mas A; Parera M; Briones C; Soriano V; Martínez MA; Domingo E; Menéndez-Arias L
    EMBO J; 2000 Nov; 19(21):5752-61. PubMed ID: 11060026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.
    Balzarini J; Pelemans H; Pérez-Pérez MJ; San-Félix A; Camarasa MJ; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 May; 49(5):882-90. PubMed ID: 8622638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
    Naeger LK; Margot NA; Miller MD
    Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance.
    Das K; Martinez SE; Arnold E
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
    Bakhanashvili M
    Oncogene; 2001 Nov; 20(52):7635-44. PubMed ID: 11753641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations.
    Tamalet C; Yahi N; Tourrès C; Colson P; Quinson AM; Poizot-Martin I; Dhiver C; Fantini J
    Virology; 2000 May; 270(2):310-6. PubMed ID: 10792990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis.
    Ray AS; Murakami E; Basavapathruni A; Vaccaro JA; Ulrich D; Chu CK; Schinazi RF; Anderson KS
    Biochemistry; 2003 Jul; 42(29):8831-41. PubMed ID: 12873144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.
    Cases-González CE; Franco S; Martínez MA; Menéndez-Arias L
    J Mol Biol; 2007 Jan; 365(2):298-309. PubMed ID: 17070543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.
    Meteer JD; Koontz D; Asif G; Zhang HW; Detorio M; Solomon S; Coats SJ; Sluis-Cremer N; Schinazi RF; Mellors JW
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3758-64. PubMed ID: 21646480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.
    Shirasaka T; Kavlick MF; Ueno T; Gao WY; Kojima E; Alcaide ML; Chokekijchai S; Roy BM; Arnold E; Yarchoan R
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2398-402. PubMed ID: 7534421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.
    Klarmann GJ; Smith RA; Schinazi RF; North TW; Preston BD
    J Biol Chem; 2000 Jan; 275(1):359-66. PubMed ID: 10617626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of multidideoxynucleoside resistance-conferring mutations in human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and error specificity.
    Rezende LF; Curr K; Ueno T; Mitsuya H; Prasad VR
    J Virol; 1998 Apr; 72(4):2890-5. PubMed ID: 9525609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1.
    Quan Y; Gu Z; Li X; Li Z; Morrow CD; Wainberg MA
    J Virol; 1996 Aug; 70(8):5642-5. PubMed ID: 8764080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.